I-SARS-CoV-2 (COVID19) idlangile emhlabeni wonke, futhi ukugoma kwamukelwa njengendlela eyonga kakhulu nephumelelayo yokulawula ubhubhane lwegciwane.Ukuhlolwa kokugoma okujwayelekile ngokuvamile kusebenzisa izindlela zokuhlonza amasosha omzimba ukuze kuhlolwe ukusebenza kahle kwemithi yokugoma ngokuhlolwa kokungathathi hlangothi;
Izindlela zendabuko zidla isikhathi futhi zisebenza kahle kancane, ngokuvamile zithatha izinsuku ezi-2 kuya kwezi-4 ukuqedela ukuhlaziya, futhi ngenxa yokuthi iningi lazo zisebenzisa amagciwane aphilayo, Kudingeka kwenziwe elabhorethri yezinga lesi-3 noma ngaphezulu, okuyisikhathi- kuyadla futhi kuyakhandleka, futhi kuletha ukuphazamiseka okukhuluekuhlolweni kokunwetshwa nokuhlanganisa.Ngakho-ke, kunesidingo esiphuthumayo sendlela ehlukile elula nesheshayo efanele ukuhlolwa kwamasosha omzimba avikelayo kubantu abaningi.
I-Aehealth COVID19 Neutralization Antibody Rapid Test Kits isetshenziselwa ukuthola amasosha omzimba e-COVID19 ku-serum yomuntu, i-plasma noma igazi lonke.Ingasetshenziselwa ukutholwa okusheshayo, okubucayi kakhulu ku-in vitro.esetshenziswa ngokomtholampilo ekuhloleni okusizayo komphumela womgomo we-COVID19 kanye nokuhlolwa kwamasosha omzimba angasebenzi ezigulini eziluleme ngemva kokutheleleka.
Ukusebenza okulula
- Asikho isidingo sokuba ochwepheshe baqeqeshwe
- Ihambisana nohlobo lwe-specimen eminingi: I-Serum/Plasma/Igazi Eliphelele/umunwe wegazi eliphelele.
Elula
- Alikho ithuluzi elidingekayo
Isebenza kahle
- Isivivinyo: 15-20 amaminithi;
Amasosha omzimba angathathi hlangothi amisa ukutheleleka ngempumelelo ngokuvimbela ukuxhumana phakathi kwegciwane le-COVID19 namaseli aphethe.Amasosha omzimba amaningi aphendula isizinda sokubopha i-receptor (RBD) sephrotheni ye-spike, ebophezela ngokuqondile ku-cell surface receptor ACE2.ama-antibodies-online okwamanje ahlinzeka ngama-antibodies amabili asuselwa ku-clone CR3022.Ngenkathi amasosha omzimba abopha i-S-protein RBD eqhudelana ngokubopha ama-antigen ne-ACE2, i-epitope ye-CR3022 ayidluleli nesayithi elibopha i-ACE2.
Ngakho-ke akuvimbeli ukubophezela kwama-antibodies e-neutralization.Ngenkathi i-CR3022 ngokwayo ikhombisa umphumela obuthakathaka wokungathathi hlangothi, kukhonjiswe ukuthi isebenzisana namanye amasosha omzimba abopha i-S-protein RBD ukuze enze i-COVID19 ingabi namandla.
